Childhood arthritis and rheumatology research alliance consensus treatment plans for new-onset polyarticular Juvenile idiopathic arthritis

Arthritis Care and Research

Volumn 66, Issue 7, 2014, Pages 1063-1072

  Ringold, Sarah ^a   Weiss, Pamela F ^b   Colbert, Robert A ^c   Dewitt, Esi Morgan ^d   Lee, Tzielan ^e   Onel, Karen ^f   Prahalad, Sampath ^g   Schneider, Rayfel ^h   Shenoi, Susan ^a   Vehe, Richard K ⁱ   Kimura, Yukiko ^j  

^a SEATTLE CHILDREN S HOSPITAL   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e STANFORD UNIVERSITY   (United States)

^f UNIVERSITY OF CHICAGO   (United States)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h HOSPITAL FOR SICK CHILDREN   (Canada)

ⁱ UNIVERSITY OF MINNESOTA   (United States)

^j HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ADALIMUMAB; CERTOLIZUMAB PEGOL; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GLUCOCORTICOID; GOLIMUMAB; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; RITUXIMAB; TOCILIZUMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL PRACTICE; COMPARATIVE EFFECTIVENESS; CONSENSUS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; HEALTH CARE SURVEY; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; OUTCOME ASSESSMENT; POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS; TREATMENT PLANNING;

ARTHRITIS, JUVENILE; CHILD; CLINICAL PROTOCOLS; CONSENSUS; EARLY DIAGNOSIS; HUMANS; PEDIATRICS; REGISTRIES; RHEUMATOLOGY;

EID: 84899833774     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22259     Document Type: Article

References (27)

1. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J, and the Diabetes Mondiale (DiaMond) Project Group. Incidence of childhood type 1 diabetes worldwide. Diabetes Care 2000; 23: 1516-26.
2. Sacks JJ, Helmick CG, Luo YH, Ilowite NT, Bowyer S,. Prevalence of and annual ambulatory health care visits for pediatric arthritis and other rheumatologic conditions in the United States in 2001-2004. Arthritis Rheum 2007; 57: 1439-45.
3. Wallace CA, Huang B, Bandeira M, Ravelli A, Giannini EH,. Patterns of clinical remission in select categories of juvenile idiopathic arthritis. Arthritis Rheum 2005; 52: 3554-62.
4. Ringold S, Seidel KD, Koepsell TD, Wallace CA, for the Childhood Arthritis and Rheumatology Research Alliance (CARRA), the Pediatric Rheumatology Collaborative Study Group (PRCSG), and the Paediatric Rheumatology International Trials Organisation (PRINTO). Inactive disease in polyarticular juvenile idiopathic arthritis: current patterns and associations. Rheumatology (Oxford) 2009; 48: 972-7.
5. Wallace CA, Giannini EH, Huang B, Itert L, Ruperto N,. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 2011; 63: 929-36.
6. Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, et al, and the Pediatric Rheumatology Collaborative Study Group. Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med 2000; 342: 763-9.
7. Lovell DJ, Ruperto N, Goodman S, Reiff A, Jung L, Jarosova K, et al, for the Pediatric Rheumatology Collaborative Study Group and Pediatric Rheumatology International Trials Organisation. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med 2008; 359: 810-20.
8. Ruperto N, Lovell DJ, Quartier P, Paz E, Rubio-Perez N, Silva CA, et al. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial. Lancet 2008; 372: 383-91.
9. Otten MH, Anink J, Spronk S, van Suijlekom-Smit LW,. Efficacy of biological agents in juvenile idiopathic arthritis: a systematic review using indirect comparisons. Ann Rheum Dis 2013; 72: 1806-12.
10. Sox HC, Greenfield, S,. Comparative effectiveness research: a report from the Institute of Medicine. Ann Intern Med 2010; 151: 203-5.
11. DeWitt EM, Kimura Y, Beukelman T, Nigrovic PA, Onel K, Prahalad S, et al, on behalf of the Juvenile Idiopathic Arthritis Disease-Specific Research Committee of Childhood Arthritis Rheumatology and Research Alliance. Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 2012; 64: 1001-10.
12. Huber AM, Robinson AB, Reed AM, Abramson L, Bout-Tabaku S, Carrasco R, et al, and the Juvenile Dermatomyositis Subcommittee of the Childhood Arthritis and Rheumatology Research Alliance. Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research Alliance consensus conference. Arthritis Care Res (Hoboken) 2012; 64: 546-53.
13. Mina R, von Scheven E, Ardoin SP, Eberhard BA, Punaro M, Ilowite N, et al, on behalf of the CARRA SLE Subcommittee. Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2012; 64: 375-83.
14. Li SC, Torok KS, Pope E, Dedeoglu F, Hong S, Jacobe HT, et al, for the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Localized Scleroderma Workgroup. Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma. Arthritis Care Res (Hoboken) 2012; 64: 1175-85.
15. Huber AM, Giannini EH, Bowyer SL, Kim S, Lang B, Lindsley CB, et al. Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Children's Arthritis and Rheumatology Research Alliance Consensus Conference. Arthritis Care Res (Hoboken) 2010; 62: 219-25.
16. Wallace CA, Giannini EH, Spalding SJ, Hashkes PJ, O'Neil KM, Zeft AS, et al, for the Childhood Arthritis and Rheumatology Research Alliance. Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. Arthritis Rheum 2012; 64: 2012-21.
17. Tynjala P, Vahasalo P, Tarkiainen M, Kroger L, Aalto K, Malin, et al. Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial. Ann Rheum Dis 2011; 70: 1605-12.
18. Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken) 2011; 63: 465-82.
19. Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004; 364: 263-9.
20. Goekoop-, Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, et al. Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial. Ann Intern Med 2007; 146: 406-15.
21. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 390-2.
22. Peeters M, Poon A,. Down syndrome and leukemia: unusual clinical aspects and unexpected methotrexate sensitivity. Eur J Pediatr 1987; 146: 416-22.
23. Lubrano E, Ciacci C, Ames PR, Mazzacca G, Oriente P, Scarpa R,. The arthritis of coeliac disease: prevalence and pattern in 200 adult patients. Br J Rheumatol 1996; 35: 1314-8.
24. Peeters MA, Rethore MO, Lejeune J,. In vivo folic acid supplementation partially corrects in vitro methotrexate toxicity in patients with Down syndrome. Br J Haematol 1995; 89: 678-80.
25. Garre ML, Relling MV, Kalwinsky D, Dodge R, Crom WR, Abromowitch M, et al. Pharmacokinetics and toxicity of methotrexate in children with Down syndrome and acute lymphocytic leukemia. J Pediatr 1987; 111: 606-12.
26. Wulffraat NM, Vastert B,. Time to share. Pediatr Rheumatol Online J 2013; 11: 5.
27. Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G, et al, for the Paediatric Rheumatology International Trials Organisation. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 2009; 61: 658-66.